CONWX
Price
$18.33
Change
-$0.19 (-1.03%)
Updated
Jul 15 closing price
Net Assets
40.52M
RLBGX
Price
$36.76
Change
-$0.14 (-0.38%)
Updated
Jul 15 closing price
Net Assets
252.32B
Interact to see
Advertisement

CONWX vs RLBGX

Header iconCONWX vs RLBGX Comparison
Open Charts CONWX vs RLBGXBanner chart's image
Concorde Wealth Management
Price$18.33
Change-$0.19 (-1.03%)
VolumeN/A
Net Assets40.52M
American Funds American Balanced R6
Price$36.76
Change-$0.14 (-0.38%)
VolumeN/A
Net Assets252.32B
CONWX vs RLBGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CONWX vs. RLBGX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CONWX is a Buy and RLBGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 252B vs. CONWX (40.5M). RLBGX pays higher dividends than CONWX: RLBGX (2.15) vs CONWX (1.42). CONWX was incepted earlier than RLBGX: CONWX (38 years) vs RLBGX (16 years). CONWX (1.62) is less costly to investors than RLBGX (0.25). RLBGX is a more actively managed with annual turnover of: 44.00 vs. CONWX (30.00). RLBGX has a lower initial minimum investment than CONWX: RLBGX (250) vs CONWX (500). RLBGX annual gain was more profitable for investors over the last year : 6.37 vs. CONWX (-0.76). RLBGX return over 5 years is better than : 40.60 vs. CONWX (25.22).
CONWXRLBGXCONWX / RLBGX
Total Expense Ratio1.620.25648%
Annual Report Gross Expense Ratio1.620.25648%
Fund Existence38 years16 years-
Gain YTD4.2217.84954%
Front LoadN/AN/A-
Min. Initial Investment500250200%
Min. Initial Investment IRAN/AN/A-
Net Assets40.5M252B0%
Annual Yield % from dividends1.422.1566%
Returns for 1 year-0.766.37-12%
Returns for 3 years6.4536.1718%
Returns for 5 years25.2240.6062%
Returns for 10 years27.8164.9543%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCLI1.20N/A
N/A
Brainstorm Cell Therapeutics
SPCE3.16-0.05
-1.56%
Virgin Galactic Holdings
SIBN16.92-0.40
-2.31%
SI-BONE
BAH104.77-2.98
-2.77%
Booz Allen Hamilton Holding Corp
CRNX31.83-1.19
-3.60%
Crinetics Pharmaceuticals